---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-005788"
form_type: "8-K"
ticker: "NUVB"
cik: "0001811063"
company_name: "Nuvation Bio Inc."
filed_at: "2022-01-10T23:59:59+00:00"
generated_at: "2026-06-27T19:33:55.474675+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Nuvation Bio reports estimated cash of $765M as of Dec. 31, 2021

## Summary
- Estimated cash, cash equivalents, and marketable securities of $765M as of December 31, 2021.
- Announcement made via Form 8-K on January 10, 2022.
- No other financial results or forward guidance provided in the filing.

## SEC filing metadata
- accession: 0001193125-22-005788
- form_type: 8-K
- ticker: NUVB
- cik: 0001811063
- company_name: Nuvation Bio Inc.
- filed_at: 2022-01-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1811063/000119312522005788/0001193125-22-005788-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1811063/000119312522005788/d276640d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-005788
- JSON: https://secwatch.observer/filing/0001193125-22-005788.json
- Plain text: https://secwatch.observer/filing/0001193125-22-005788.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.